ATE320254T1 - Crf receptor antagonisten - Google Patents

Crf receptor antagonisten

Info

Publication number
ATE320254T1
ATE320254T1 AT02718405T AT02718405T ATE320254T1 AT E320254 T1 ATE320254 T1 AT E320254T1 AT 02718405 T AT02718405 T AT 02718405T AT 02718405 T AT02718405 T AT 02718405T AT E320254 T1 ATE320254 T1 AT E320254T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
crf receptor
crf
antagonists
receptor
Prior art date
Application number
AT02718405T
Other languages
English (en)
Inventor
Fabio Romano Di
Fabrizio Micheli
Alessandra Pasquarello
Yves St-Denis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0110579A external-priority patent/GB0110579D0/en
Priority claimed from GB0110566A external-priority patent/GB0110566D0/en
Priority claimed from GB0117423A external-priority patent/GB0117423D0/en
Priority claimed from GB0203203A external-priority patent/GB0203203D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE320254T1 publication Critical patent/ATE320254T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02718405T 2001-04-30 2002-04-30 Crf receptor antagonisten ATE320254T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0110579A GB0110579D0 (en) 2001-04-30 2001-04-30 Chemical compounds
GB0110566A GB0110566D0 (en) 2001-04-30 2001-04-30 Chemical compounds
GB0117423A GB0117423D0 (en) 2001-07-17 2001-07-17 Chemical compounds
GB0203203A GB0203203D0 (en) 2002-02-11 2002-02-11 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE320254T1 true ATE320254T1 (de) 2006-04-15

Family

ID=27447943

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718405T ATE320254T1 (de) 2001-04-30 2002-04-30 Crf receptor antagonisten

Country Status (21)

Country Link
US (1) US7329667B2 (de)
EP (1) EP1383498B1 (de)
JP (1) JP2004528342A (de)
KR (1) KR20040015205A (de)
CN (1) CN1512883A (de)
AR (1) AR033296A1 (de)
AT (1) ATE320254T1 (de)
AU (1) AU2002249474B2 (de)
BR (1) BR0209035A (de)
CA (1) CA2446497A1 (de)
CZ (1) CZ20032945A3 (de)
DE (1) DE60209885T2 (de)
ES (1) ES2255610T3 (de)
HU (1) HUP0304035A2 (de)
IL (1) IL158063A0 (de)
MX (1) MXPA03009930A (de)
NO (1) NO20034837L (de)
NZ (1) NZ528364A (de)
PL (1) PL366854A1 (de)
TW (1) TWI236908B (de)
WO (1) WO2002087573A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
HUE026518T2 (en) * 2009-06-08 2016-06-28 Takeda Pharmaceuticals Co Dihydro-pyrrolo-naphthyridinone compounds as JAK inhibitors
RU2498986C2 (ru) * 2011-07-20 2013-11-20 Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран) ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
ZA973884B (en) 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
WO2000027846A2 (en) * 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
JP2002529469A (ja) * 1998-11-12 2002-09-10 ニューロクライン バイオサイエンシーズ， インコーポレイテッド Ｃｒｆレセプターアンタゴニストおよびそれに関する方法
GB0117395D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP2004528342A (ja) 2004-09-16
PL366854A1 (en) 2005-02-07
AR033296A1 (es) 2003-12-10
CN1512883A (zh) 2004-07-14
CZ20032945A3 (cs) 2004-02-18
IL158063A0 (en) 2004-03-28
US20040235871A1 (en) 2004-11-25
ES2255610T3 (es) 2006-07-01
US7329667B2 (en) 2008-02-12
CA2446497A1 (en) 2002-11-07
NZ528364A (en) 2005-12-23
NO20034837L (no) 2003-12-09
EP1383498B1 (de) 2006-03-15
DE60209885D1 (de) 2006-05-11
TWI236908B (en) 2005-08-01
MXPA03009930A (es) 2004-01-29
AU2002249474B2 (en) 2006-01-12
BR0209035A (pt) 2004-08-10
KR20040015205A (ko) 2004-02-18
HUP0304035A2 (hu) 2004-04-28
NO20034837D0 (no) 2003-10-29
WO2002087573A1 (en) 2002-11-07
DE60209885T2 (de) 2006-08-10
EP1383498A1 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
ATE346043T1 (de) Il-8-rezeptorantagonisten
NO20025754L (no) IL-8 Reseptor-antagonister
ATE439344T1 (de) Muscarin-antagonisten
DE60332816D1 (de) Nk1-antagonisten
ATE299698T1 (de) Il-8 rezeptor antagonisten
SI1425280T1 (sl) Hetero-biciklicni antagonisti crf
DK1261336T3 (da) IL-8-receptorantagonister
DE60222693D1 (de) Nk1-antagonisten
DE60130000D1 (de) Zwitterionische tachykinin-rezeptor-antagonisten
MA25739A1 (fr) Antagonistes recepteurs il-8
DE60226419D1 (de) Somatostatin-antagonisten
DK1180028T3 (da) IL-8-receptorantagonister
MA25659A1 (fr) Antagonistes recepteurs il-8
NO20033223L (no) Histamin-reseptor antagonister
NO20015774D0 (no) IL-8 reseptorantagonister
ATE370932T1 (de) Ccr-3-rezeptorantagonisten vii
DE60209885D1 (de) Crf receptor antagonisten
NO20024366D0 (no) IL-8 reseptorantagonister
SE0003996D0 (sv) Receptorantagonister

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties